Sonendo signs non-binding LOI to serve as stalking horse bidder for Biolase assets in Ch. 11

Sonendo, Inc.

Wholly-owned subsidiary entered non-binding LOI on Aug 30, 2024 with Biolase, Inc.
Sonendo evaluating role as stalking horse bidder for Biolase's potential Chapter 11 in Delaware.
Engaged Craig-Hallum Capital Group and Stifel to assist in evaluation.
Transaction would involve purchase of Biolase assets; no definitive agreement yet.
All advisers are assisting with due diligence and strategic assessment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.